{
  "nct_id": "NCT12345680",
  "indication": "Hypertension",
  "phase": "Phase 2",
  "sample_size": 150,
  "duration_weeks": 12,
  "dropout_rate": 0.28,
  "primary_endpoints": ["Blood pressure reduction >=5 mmHg"],
  "control_arm": "placebo",
  "blinding": "double-blind",
  "outcome_summary": "Failed to meet primary endpoint, no significant difference vs placebo",
  "failure_reason": "Insufficient efficacy"
}